304 related articles for article (PubMed ID: 29577276)
1. Soluble γc receptor attenuates anti-tumor responses of CD8
Kim G; Hwang H; Jo Y; Lee B; Lee YH; Kim CH; Hong C
Int J Cancer; 2018 Sep; 143(5):1212-1223. PubMed ID: 29577276
[TBL] [Abstract][Full Text] [Related]
2. A soluble form of the murine common gamma chain is present at high concentrations in vivo and suppresses cytokine signaling.
Meissner U; Blum H; Schnare M; Röllinghoff M; Gessner A
Blood; 2001 Jan; 97(1):183-91. PubMed ID: 11133759
[TBL] [Abstract][Full Text] [Related]
3. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
[TBL] [Abstract][Full Text] [Related]
4. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
5. Soluble γc cytokine receptor suppresses IL-15 signaling and impairs iNKT cell development in the thymus.
Park JY; Jo Y; Ko E; Luckey MA; Park YK; Park SH; Park JH; Hong C
Sci Rep; 2016 Nov; 6():36962. PubMed ID: 27833166
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
Mueller K; Schweier O; Pircher H
Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes.
Lu J; Giuntoli RL; Omiya R; Kobayashi H; Kennedy R; Celis E
Clin Cancer Res; 2002 Dec; 8(12):3877-84. PubMed ID: 12473603
[TBL] [Abstract][Full Text] [Related]
9. Different strategies for producing naturally soluble form of common cytokine receptor γ chain.
Jeong J; Kim WH; Fernandez CP; Kim S; Kim YH; Jang HK; Lillehoj HS; Woo HJ; Min W
Dev Comp Immunol; 2015 Jan; 48(1):13-21. PubMed ID: 25173813
[TBL] [Abstract][Full Text] [Related]
10. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
11. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
[TBL] [Abstract][Full Text] [Related]
12. Specific Inhibition of Soluble γc Receptor Attenuates Collagen-Induced Arthritis by Modulating the Inflammatory T Cell Responses.
Lee B; Jo Y; Kim G; Ali LA; Sohn DH; Lee SG; Kim K; Shin E; Ryu SH; Hong C
Front Immunol; 2019; 10():209. PubMed ID: 30800133
[TBL] [Abstract][Full Text] [Related]
13. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
[TBL] [Abstract][Full Text] [Related]
14. Soluble common gamma chain exacerbates COPD progress through the regulation of inflammatory T cell response in mice.
Lee B; Ko E; Lee J; Jo Y; Hwang H; Goh TS; Joo M; Hong C
Int J Chron Obstruct Pulmon Dis; 2017; 12():817-827. PubMed ID: 28331303
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
16. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.
Guo S; Smeltz RB; Nanajian A; Heller R
Front Immunol; 2020; 11():614667. PubMed ID: 33628206
[TBL] [Abstract][Full Text] [Related]
17. The Potential Role of a Soluble γ-Chain Cytokine Receptor as a Regulator of IL-7-Induced Lymphoproliferative Disorders.
Kim G; Jo Y; Lee B; Ali LA; Lee B; Hong C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373315
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 Modulates Anti-Tumor CD8+ T Cell Responses via Its Action on Host Cells.
Deiser K; Stoycheva D; Bank U; Blankenstein T; Schüler T
PLoS One; 2016; 11(7):e0159690. PubMed ID: 27447484
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
Rowley J; Monie A; Hung CF; Wu TC
J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
[TBL] [Abstract][Full Text] [Related]
20. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.
Rosenthal R; Groeper C; Bracci L; Adamina M; Feder-Mengus C; Zajac P; Iezzi G; Bolli M; Weber WP; Frey DM; von Holzen U; Oertli D; Heberer M; Spagnoli GC
J Immunother; 2009 Apr; 32(3):252-61. PubMed ID: 19242375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
